The following data is part of a premarket notification filed by American Healthcare Inc. with the FDA for Blood Glucose Monitoring System.
Device ID | K043543 |
510k Number | K043543 |
Device Name: | BLOOD GLUCOSE MONITORING SYSTEM |
Classification | System, Test, Blood Glucose, Over The Counter |
Applicant | AMERICAN HEALTHCARE INC. 304 PARK AVENUE SOUTH SUITE 218 New York, NY 10010 -4301 |
Contact | Edward Letko |
Correspondent | Edward Letko AMERICAN HEALTHCARE INC. 304 PARK AVENUE SOUTH SUITE 218 New York, NY 10010 -4301 |
Product Code | NBW |
CFR Regulation Number | 862.1345 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2004-12-20 |
Decision Date | 2005-04-08 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00885502001041 | K043543 | 000 |
00885502000044 | K043543 | 000 |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BLOOD GLUCOSE MONITORING SYSTEM 98453047 not registered Live/Pending |
Shenzhen Wangzhi Technology Co., Ltd. 2024-03-16 |